[Federal Register Volume 80, Number 150 (Wednesday, August 5, 2015)]
[Notices]
[Page 46604]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19173]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Patheon 
Pharmaceuticals, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Patheon Pharmaceuticals, Inc. applied to be registered as a 
manufacturer of a certain basic class of controlled substance. The Drug 
Enforcement Administration (DEA) grants Patheon Pharmaceuticals, Inc. 
registration as a manufacturer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated March 9, 2015, and published 
in the Federal Register on March 24, 2015, 80 FR 15632, Patheon 
Pharmaceuticals, Inc., 2110 E. Galbraith Road, Cincinnati, Ohio 45237 
applied to be registered as a manufacturer of a certain basic class of 
controlled substance. No comments or objections were submitted for this 
notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Patheon Pharmaceuticals, Inc. to 
manufacture the basic class of controlled substance is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of gamma hydroxybutyric acid (2010), a basic class of 
controlled substance listed in schedule I.
    The company plans to manufacturer the listed controlled substance 
for distribution to its customers.

    Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19173 Filed 8-4-15; 8:45 am]
 BILLING CODE P